Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-008842
Filing Date
2022-04-08
Accepted
2022-04-08 17:06:28
Documents
166
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F nbx-20211231.htm   iXBRL 20-F 6045474
2 EX-2.3 nanobiotix-secx20xf2021xexe.htm EX-2.3 205892
3 EX-4.5 nanobiotix-secx20xf2021xex.htm EX-4.5 415962
4 EX-4.6 nanobiotix-secx20xf2021xexa.htm EX-4.6 4890
5 EX-4.7 nanobiotix-secx20xf2021xexb.htm EX-4.7 4580
6 EX-4.4.1 nanobiotix-secx20xf2021xexc.htm EX-4.4.1 25267
7 EX-12.1 nanobiotix-secx20xf2021xexf.htm EX-12.1 9832
8 EX-12.2 nanobiotix-secx20xf2021xexg.htm EX-12.2 9922
9 EX-13.1 nanobiotix-secx20xf2021xexh.htm EX-13.1 5830
10 EX-13.2 nanobiotix-secx20xf2021xexi.htm EX-13.2 5812
11 EX-15.1 nanobiotix-secx20xf2021xexd.htm EX-15.1 3665
17 nbx-20211231_g1.jpg GRAPHIC 198199
18 nbx-20211231_g10.jpg GRAPHIC 83808
19 nbx-20211231_g11.jpg GRAPHIC 38997
20 nbx-20211231_g12.jpg GRAPHIC 63940
21 nbx-20211231_g13.jpg GRAPHIC 53873
22 nbx-20211231_g14.jpg GRAPHIC 106908
23 nbx-20211231_g15.jpg GRAPHIC 32374
24 nbx-20211231_g16.jpg GRAPHIC 34773
25 nbx-20211231_g17.jpg GRAPHIC 40297
26 nbx-20211231_g18.jpg GRAPHIC 56484
27 nbx-20211231_g19.jpg GRAPHIC 55425
28 nbx-20211231_g2.jpg GRAPHIC 31027
29 nbx-20211231_g20.jpg GRAPHIC 90810
30 nbx-20211231_g21.jpg GRAPHIC 38889
31 nbx-20211231_g22.jpg GRAPHIC 43908
32 nbx-20211231_g23.jpg GRAPHIC 38174
33 nbx-20211231_g24.jpg GRAPHIC 44745
34 nbx-20211231_g25.jpg GRAPHIC 63227
35 nbx-20211231_g26.jpg GRAPHIC 84654
36 nbx-20211231_g27.jpg GRAPHIC 51345
37 nbx-20211231_g28.jpg GRAPHIC 45234
38 nbx-20211231_g3.jpg GRAPHIC 91507
39 nbx-20211231_g4.jpg GRAPHIC 53102
40 nbx-20211231_g5.jpg GRAPHIC 132124
41 nbx-20211231_g6.jpg GRAPHIC 19879
42 nbx-20211231_g7.jpg GRAPHIC 19296
43 nbx-20211231_g8.jpg GRAPHIC 117872
44 nbx-20211231_g9.jpg GRAPHIC 18887
  Complete submission text file 0001628280-22-008842.txt   29708424

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbx-20211231.xsd EX-101.SCH 137570
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbx-20211231_cal.xml EX-101.CAL 84371
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbx-20211231_def.xml EX-101.DEF 644115
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbx-20211231_lab.xml EX-101.LAB 1101440
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbx-20211231_pre.xml EX-101.PRE 888634
160 EXTRACTED XBRL INSTANCE DOCUMENT nbx-20211231_htm.xml XML 5701821
Mailing Address 60 RUE DE WATTIGNIES PARIS I0 75012
Business Address 60 RUE DE WATTIGNIES PARIS I0 75012 33140260470
Nanobiotix S.A. (Filer) CIK: 0001760854 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39777 | Film No.: 22817787
SIC: 2834 Pharmaceutical Preparations